Baruch Samuel Blumberg

(redirected from Baruch S. Blumberg)
Also found in: Medical.

Blumberg, Baruch Samuel

 

Born July 28, 1925, in New York. American physician.

Blumberg graduated from Union College in Schenectady in 1946 and received his M.D. from Columbia University in 1951. From 1957 to 1964 he was head of the geographic medicine and genetics section at the National Institutes of Health in Bethesda. In 1964 he was appointed director of clinical research at the Institute of Cancer Research in Philadelphia; in 1970 he became a professor of medicine and medical genetics at the University of Pennsylvania.

In 1964, Blumberg discovered the Australia antigen in human blood serum. The antigen plays an important role in the development of serum hepatitis; its discovery made possible a reduction in the incidence of serum hepatitis through laboratory techniques for screening the blood received from donors.

Blumberg received a Nobel Prize in 1976.

Mentioned in ?
References in periodicals archive ?
Timothy Block, President and Co-founder of the biotech center and president of the Hepatitis B Foundation and the Baruch S. Blumberg Institute.
Today, Sofia serves on the faculty of the Baruch S. Blumberg Institute, the research institute of the Hepatitis B Foundation, and is Chief Scientific Officer of Arbutus Biopharma.
Block, president of the Baruch S. Blumberg Institute and the Pennsylvania Biotechnology Center.
Baruch S. Blumberg, who received the Nobel Prize in Medicine in 1976 for his discovery of the hepatitis B virus.
The Baruch S. Blumberg Institute and The Commonwealth Medical College (TCMC) will hold an open house for participants to learn about a new Master of Biomedical Science (MBS) program and meet with faculty, admissions counselors and financial aid representatives.
Timothy Block, president and co-founder of the Hepatitis B Foundation and its research arm, the Baruch S. Blumberg Institute.
The Baruch S. Blumberg Institute, the research arm of the Hepatitis B Foundation, will host the 15th Annual Regional Biotech Conference, themed "Decreasing the Cost of Drug Development," at its headquarters at the Pennsylvania Biotechnology Center in Doylestown, Pennsylvania.
Doylestown, PA, July 25, 2015 --(PR.com)-- The Baruch S. Blumberg Institute on July 16 hosted the inaugural "Entrepreneur Spotlight" at the Pennsylvania Biotechnology Center of Bucks County, attracting biotech executives and business leaders from across the region to the Shark Tank-style program and awards ceremony.
Eugene Schiff, Director of the Schiff Center for Liver Diseases at the University of Miami Miller School of Medicine, was awarded the 2015 Baruch S. Blumberg Prize, the highest scientific honor that the foundation confers, for his pioneering work in hepatitis B and its medical management.
Doylestown, PA, May 03, 2015 --(PR.com)-- The Baruch S. Blumberg Institute (www.blumberginstitute.org) and the University of Pennsylvania have formed a partnership that will offer graduate students valuable laboratory experience while bringing additional research support to the Institute's research programs.
Doylestown, PA, March 28, 2015 --(PR.com)-- The Baruch S. Blumberg Institute (www.blumberginstitute.org) has recruited a new team of nationally renowned scientists to focus exclusively on research to develop a cure for hepatitis B, a move that nearly triples its research capacity and has created the largest concentration of nonprofit scientists focusing solely on hepatitis B and liver cancer in the United States.
Formerly the chief operating officer of a national behavioral health organization, Kassa will oversee daily operations at the Pennsylvania Biotech Center, which is home to the Hepatitis B Foundation and its research entity, the Baruch S. Blumberg Institute.